K.J. Harrison & Partners Inc bought a new stake in DocuSign, Inc. (NASDAQ:DOCU – Free Report) in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm bought 3,000 shares of the company’s stock, valued at approximately $271,000.
A number of other hedge funds and other institutional investors also recently bought and sold shares of DOCU. Itau Unibanco Holding S.A. acquired a new stake in shares of DocuSign in the third quarter valued at about $28,000. Kestra Investment Management LLC acquired a new position in DocuSign during the fourth quarter worth about $30,000. Brooklyn Investment Group purchased a new position in DocuSign in the third quarter valued at about $33,000. Modus Advisors LLC acquired a new stake in shares of DocuSign during the 4th quarter valued at approximately $36,000. Finally, First Horizon Advisors Inc. lifted its position in shares of DocuSign by 102.6% during the 4th quarter. First Horizon Advisors Inc. now owns 397 shares of the company’s stock valued at $36,000 after acquiring an additional 201 shares during the period. Institutional investors and hedge funds own 77.64% of the company’s stock.
Insider Activity
In related news, Director Teresa Briggs sold 534 shares of the firm’s stock in a transaction that occurred on Monday, December 16th. The shares were sold at an average price of $94.60, for a total value of $50,516.40. Following the sale, the director now directly owns 7,736 shares of the company’s stock, valued at approximately $731,825.60. This trade represents a 6.46 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, CFO Blake Jeffrey Grayson sold 8,000 shares of the business’s stock in a transaction on Friday, February 14th. The shares were sold at an average price of $86.90, for a total transaction of $695,200.00. Following the sale, the chief financial officer now directly owns 77,851 shares of the company’s stock, valued at $6,765,251.90. This represents a 9.32 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 693,773 shares of company stock valued at $66,727,926 over the last quarter. Company insiders own 1.66% of the company’s stock.
DocuSign Stock Performance
Analyst Upgrades and Downgrades
Several research firms recently weighed in on DOCU. HSBC reaffirmed a “reduce” rating on shares of DocuSign in a research note on Friday, December 6th. UBS Group raised their price target on DocuSign from $60.00 to $100.00 and gave the company a “neutral” rating in a research report on Friday, December 6th. Citigroup lifted their price target on DocuSign from $87.00 to $113.00 and gave the stock a “buy” rating in a research note on Friday, December 6th. Needham & Company LLC reissued a “hold” rating on shares of DocuSign in a research note on Tuesday, February 4th. Finally, Jefferies Financial Group increased their price target on shares of DocuSign from $80.00 to $95.00 and gave the company a “buy” rating in a research report on Tuesday, December 3rd. Three equities research analysts have rated the stock with a sell rating, seven have assigned a hold rating and three have given a buy rating to the company. According to MarketBeat.com, the stock presently has an average rating of “Hold” and a consensus target price of $92.45.
Get Our Latest Stock Report on DocuSign
About DocuSign
DocuSign, Inc provides electronic signature solution in the United States and internationally. The company provides e-signature solution that enables sending and signing of agreements on various devices; Contract Lifecycle Management (CLM), which automates workflows across the entire agreement process; Document Generation streamlines the process of generating new, custom agreements; and Gen for Salesforce, which allows sales representatives to automatically generate agreements with a few clicks from within Salesforce.
Read More
- Five stocks we like better than DocuSign
- 3 Stocks to Protect Your Portfolio from the Coronavirus Contagion
- Volatility Is Back: 3 Stocks To Cushion the S&P 500’s Swings
- The Top 3 Healthcare Dividend Stocks to Buy and Hold
- 2 Catalysts That Could Push NVIDIA Stock Up 30% This Year
- The 3 Best Fintech Stocks to Buy Now
- Do GM Stock Buybacks Make the Stock Buyable For Investors?
Receive News & Ratings for DocuSign Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DocuSign and related companies with MarketBeat.com's FREE daily email newsletter.